RFK Jr. Once Again Coming For Your SSRIs Robert F. Kennedy Jr. is advocating for a reduction in antidepressant use, promoting non-pharmacological interventions like therapy and exercise as primary treatments. The article critiques this stance, asserting that SSRIs are often necessary first-line treatments for clinical depression and that Kennedy’s claims about their addictiveness and equivalence to heroin withdrawal are unfounded. The author emphasizes the importance of these medications for many individuals and warns against unqualified opinions influencing mental health policy.

• Robert F. Kennedy Jr. plans to curb the use of antidepressants, advocating for non-pharmacological treatments.
• Kennedy claims expertise based on his past heroin addiction, suggesting SSRIs are harder to quit than heroin.
• The article disputes Kennedy’s claims, stating SSRIs are not addictive and are crucial for treating clinical depression.
• The author criticizes the New York Times for uncritically presenting Kennedy’s views.
• Concerns are raised about the healthcare system’s profit motive and disparities in treatment access and research.